Clinical Perspectives

Phase 1 Trial: Evaluating Claudin18.2-Specific CAR T Cells in Gastrointestinal Cancers

A phase 1 clinical trial evaluates the effectiveness of CLDN18.2-targeted CAR-T cells in digestive system cancers.

Identification of Targetable Gene Fusions Present in KRASWT Pancreatic Adenocarcinoma and the Response to Targeted Therapy

Study shows Oncogene fusions are present in KRASWT pancreatic adenocarcinomas at an increased frequency when compared with KRASMUT pancreatic...

A New Approach to Cancer Diagnostics

Moffitt's Diagnostic Imaging and Interventional Radiology Program provides the highest level of diagnosis services resulting in the most effective...

5-ALA is Transforming the Treatment of Glioblastoma

By enhancing a surgeon’s ability to clearly visualize the boundaries of the tumor, 5-ALA-guided tumor resection can provide a tremendous advantage.

Innovative Margin Assessment Technology Presents Positive Outcomes in Breast Cancer Surgery

Moffitt's Dr. Marie Lee tests the effectiveness of the SELENE System on positive margin rates in breast lumpectomy surgery for cancer.

Moffitt Connecting National Experts for Myeloma Immunotherapy Breakthroughs

The Multiple Myeloma Cellular Therapy Consortium, an alliance of CAR T-cell therapy programs nationwide, has created the largest cohort of multiple...

Using CUE-101 in Combination with Pembrolizumab in Treating Recurrent/Metastatic HPV16+ Head and Neck Cancer

Dr. Chung presents her research findings at SITC when combining CUE-101 with Pembrolizumab, a monotherapy in treating HPV16+ recurrent/metastatic...

Dr. Ahmed Tests the Response of Systemic Therapies or Radiation Across Different Metastatic Disease Sites

Study presented at 2022 ASTRO presents outcomes of systemic therapies or radiation across various metastatic disease sites.

MRgSBRT Demonstrates Advantages in Treatment for Adrenal Gland Metastases

Magnetic resonance guided SBRT (MRgSBRT) shows better response than CT-based stereotactic body radiation therapy (SGRT) in treating adrenal gland...

8 Reasons to Consider Clinical Trials First

For patients facing cancer, their first chance is their best chance, and that means considering all options at the time of diagnosis, including...

Better Outcomes for Lung Cancer Using Robotic Bronchoscope

Moffitt Cancer Center is now using innovative new endoscopic technology to better diagnose lung cancer.

Lung Cancer in Nonsmokers May be Linked to Air Pollution

Environmental exposures such as tobacco smoke, radiation, asbestos and radium, can trigger lung cancer in nonsmokers.

Dr. Chen Presents Research Findings from Cutaneous T-cell Lymphoma Study

Dr. Pei-Ling Chen joined OncLive On Air to share insight and research findings on CTCL and racial disparities in patients.

Cysview Blue Light Cystoscopy Technology for Bladder Cancer Available at Moffitt Cancer Center

A new imaging technology, called Cysview Blue Light Cystoscopy (BLC), can be used to help bladder cancer surgeons to better detect and remove as many...

Top Treatment Developments in Cancer Care

Moffitt’s notable breakthroughs include advancements in fluorescent imaging, personalized medicine through mathematics and a better understanding of...